- Home
- IIIV vs MGTX Comparison
IIIV vs MGTX Comparison
Compare IIIV & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IIIV
- MGTX
- Stock Information
- Founded
- IIIV 2012
- MGTX 2015
- Country
- IIIV United States
- MGTX United States
- Employees
- IIIV N/A
- MGTX N/A
- Industry
- IIIV EDP Services
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IIIV Technology
- MGTX Health Care
- Exchange
- IIIV Nasdaq
- MGTX Nasdaq
- Market Cap
- IIIV 720.4M
- MGTX 670.2M
- IPO Year
- IIIV 2018
- MGTX N/A
- Fundamental
- Price
- IIIV $30.78
- MGTX $7.33
- Analyst Decision
- IIIV Buy
- MGTX Strong Buy
- Analyst Count
- IIIV 6
- MGTX 2
- Target Price
- IIIV $34.33
- MGTX $24.00
- AVG Volume (30 Days)
- IIIV 182.1K
- MGTX 284.2K
- Earning Date
- IIIV 08-07-2025
- MGTX 11-12-2025
- Dividend Yield
- IIIV N/A
- MGTX N/A
- EPS Growth
- IIIV N/A
- MGTX N/A
- EPS
- IIIV 5.56
- MGTX N/A
- Revenue
- IIIV $248,271,000.00
- MGTX $37,917,000.00
- Revenue This Year
- IIIV N/A
- MGTX $145.67
- Revenue Next Year
- IIIV $3.86
- MGTX $167.61
- P/E Ratio
- IIIV $5.51
- MGTX N/A
- Revenue Growth
- IIIV 25.08
- MGTX 366.84
- 52 Week Low
- IIIV $20.42
- MGTX $3.94
- 52 Week High
- IIIV $33.44
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- IIIV 52.24
- MGTX 42.71
- Support Level
- IIIV $29.99
- MGTX $7.39
- Resistance Level
- IIIV $31.20
- MGTX $7.91
- Average True Range (ATR)
- IIIV 0.87
- MGTX 0.36
- MACD
- IIIV -0.12
- MGTX -0.00
- Stochastic Oscillator
- IIIV 56.43
- MGTX 19.89
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.